Organism name | Daucus carota |
---|---|
Genus | Daucus |
Family | Apiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Daucus carota |
---|---|
Linked NCBI taxonomy ID | 4039 |
Linked level | species |
Family in NCBI taxonomy | Apiaceae |
---|---|
ID | 4037 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Daucus carota L. subsp. Carota | Antilithic |
Daucus carota L. subsp. Carota | Aphrodisiac |
Daucus carota L. subsp. Carota | Cardioactive |
Daucus carota L. subsp. Carota | Carminative |
Daucus carota L. subsp. Carota | Chemopreventive |
Daucus carota L. subsp. Carota | Contraceptive |
Daucus carota L. subsp. Carota | Diuretic |
Daucus carota L. subsp. Carota | Emmenagogue |
Daucus carota L. subsp. Carota | Hepatoprotective |
Daucus carota L. subsp. Carota | Hypotensive |
Daucus carota L. subsp. Carota | Myorelaxant |
Daucus carota L. subsp. Carota | Vasdodilator |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006655
![]() |
Cyanidin 3-lathyroside
|
No. 1 | No. 15 |
![]() |
||||
C00001067
![]() |
Luteolin 7-O-(6''-malonylglucoside)
|
No. 2 | No. 15 |
![]() |
||||
C00002374
![]() |
Chrysanthemin
/ Cyanidin 3-O-glucoside |
CHEMBL257839
CHEMBL1197952 |
C114438
|
1 / 0 / 1 | No. 2 | No. 15 |
![]() |
|
C00006670
![]() |
Cyanidin 3-glucosyl-(1->6)-[xylosyl-(1->2)-galactoside]
|
No. 5 | No. 15 |
![]() |
||||
C00006832
![]() |
Cyanidin 3-[6-(6-p-coumarylglucosyl)-2-xylosylgalactoside]
|
No. 7 | No. 15 |
![]() |
||||
C00006833
![]() |
Cyanidin 3-[6-(6-ferulylglucosyl)-2-xylosylgalactoside]
|
No. 7 | No. 15 |
![]() |
||||
C00006834
![]() |
Cyanidin 3-[6-(6-sinapylglucosyl)-2-xylosylgalactoside]
|
No. 7 | No. 15 |
![]() |
||||
C00006831
![]() |
Cyanidin 3-[6-(6-p-hydroxybenzoylglucosyl)-2-xylosylgalactoside]
|
No. 7 | No. 15 |
![]() |
||||
C00000919
![]() |
beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
D019207
|
7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |
![]() |
C00003765
![]() |
alpha-Carotene
|
No. 26 | No. 59 |
![]() |
||||
C00000007
![]() |
GA7
/ Gibberellin A7 |
No. 40 | No. 41 |
![]() |
||||
C00000004
![]() |
GA4
/ Gibberellin A4 |
No. 40 | No. 41 |
![]() |
||||
C00000001
![]() |
GA1
/ Gibberellin A1 |
C422660
|
No. 40 | No. 41 |
![]() |
|||
C00004330
![]() |
Luteolin 4'-sulfate
|
No. 51 | No. 15 |
![]() |
||||
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00000934
![]() |
zeta-Carotene
|
No. 97 | No. 59 |
![]() |
||||
C00003766
![]() |
delta-Carotene
|
No. 131 | No. 59 |
![]() |
||||
C00000926
![]() |
gamma-Carotene
|
No. 131 | No. 59 |
![]() |
||||
C00002760
![]() |
Methylisoeugenol
|
CHEMBL465829
CHEMBL1164609 |
No. 310 | No. 6 |
![]() |
|||
C00021417
![]() |
Carota-1,4-beta-oxide
|
No. 392 | No. 38 |
![]() |
||||
C00003124
![]() |
Daucol
|
No. 392 | No. 38 |
![]() |
||||
C00007242
![]() |
beta-Bisabolene
/ l-beta-Bisabolene / (-)-beta-Bisabolene |
CHEMBL444389
CHEMBL1077088 CHEMBL2001434 |
No. 701 | No. 38 |
![]() |
|||
C00002739
![]() |
Elemicin
|
CHEMBL458690
|
C002135
|
No. 723 | No. 6 |
![]() |
||
C00001283
![]() |
Falcarindiol
|
CHEMBL69018
CHEMBL1094112 |
C034379
|
3 / 0 / 0 | No. 940 | No. 69 |
![]() |
|
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00003109
![]() |
Carotol
|
No. 1187 | No. 38 |
![]() |
||||
C00001497
![]() |
3' 5'-cyclic AMP
|
CHEMBL9871
CHEMBL316966 CHEMBL1365681 CHEMBL1416083 CHEMBL1741513 CHEMBL2359042 |
D000242
|
29 / 24 / 19 | 80 / 7 | No. 1201 |
![]() |
|
C00003004
![]() |
6-Methoxymellein
|
CHEMBL449604
|
No. 1274 |
![]() |
||||
C00000554
![]() |
6HM
/ 6-Hydroxymellein |
CHEMBL446047
|
C070622
|
No. 1274 |
![]() |
|||
C00002762
![]() |
Myristicin
|
CHEMBL481044
|
C005246
|
6 / 4 / 2 | 2 / 0 | No. 1917 | No. 6 |
![]() |
C00000094
![]() |
2iP
/ N6-(delta2-Isopentenyl)adenine |
CHEMBL476189
|
C001478
|
5 / 2 / 3 | 18 / 0 | No. 2879 |
![]() |
|
C00021380
![]() |
Daucene
|
No. 4056 | No. 38 |
![]() |
||||
C00002491
![]() |
Peucedanin
|
CHEMBL1410943
|
10 / 8 / 6 | No. 4483 | No. 25 |
![]() |
||
C00001533
![]() |
Cucumopine
|
C082688
|
No. 6474 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00000911 C00000919 C00001497 C00002762 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000919 C00002491 C00002762 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000094 C00001497 C00002762 | 0 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 C00001497 C00002491 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000911 C00000919 C00001497 | 11 / 10 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 C00001497 C00002491 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000094 C00001497 | 1 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 C00001497 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000094 C00001497 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000094 C00001497 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000094 C00001497 | 0 / 1 |
O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00001497 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001497 | 3 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00001497 | 1 / 2 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001283 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001283 | 0 / 0 |
Q9Y694 | Solute carrier family 22 member 7 | Unclassified protein | C00001497 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002491 | 2 / 2 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00002374 | 0 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002491 | 2 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001497 | 0 / 0 |
Q16280 | Cyclic nucleotide-gated olfactory channel | Unclassified protein | C00001497 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001497 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001283 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001497 | 1 / 1 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001497 | 1 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002762 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001497 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002491 | 3 / 3 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002491 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002491 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001497 | 2 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002491 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002762 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001497 | 1 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002491 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002762 | 4 / 1 |
Q8WZA2 | Rap guanine nucleotide exchange factor 4 | Unclassified protein | C00001497 | 0 / 0 |
O15440 | Multidrug resistance-associated protein 5 | Unclassified protein | C00001497 | 0 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00001497 | 0 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00001497 | 0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00001497 | 0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00001497 | 1 / 0 |
Q96J66 | ATP-binding cassette sub-family C member 11 | Unclassified protein | C00001497 | 1 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 | 0 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 | 1 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
C00000919
C00002762
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
C00000919
C00001497
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
C00000919
C00001497
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
C00000919
C00001497
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
C00001497
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
C00000919
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
C00000919
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
C00001497
|
3713 | IVL | involucrin |
C00000911
C00000919
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
C00001497
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000919
C00001497
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000919
C00001497
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
C00001497
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
C00001497
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000094
C00001497
|
3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 |
C00000919
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000094
|
7431 | VIM, CTRCT30 | vimentin |
C00000094
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002762
|
7029 | TFDP2, DP2 | transcription factor Dp-2 (E2F dimerization partner 2) |
C00000094
|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000094
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
|
6016 | RIT1, NS8, RIBB, RIT, ROC1 | Ras-like without CAAX 1 |
C00000094
|
898 | CCNE1, CCNE | cyclin E1 |
C00000911
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000911
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00000094
|
5774 | PTPN3, PTP-H1, PTPH1 | protein tyrosine phosphatase, non-receptor type 3 (EC:3.1.3.48) |
C00000094
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
5782 | PTPN12, PTP-PEST, PTPG1 | protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48) |
C00000094
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
9360 | PPIG, CARS-Cyp, CYP, SCAF10, SRCyp | peptidylprolyl isomerase G (cyclophilin G) (EC:5.2.1.8) |
C00000094
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000094
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00000094
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00000094
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
9818 | NUPL1, PRO2463 | nucleoporin like 1 |
C00000094
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
182 | JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1 | jagged 1 |
C00000094
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001497
|
116 | ADCYAP1, PACAP | adenylate cyclase activating polypeptide 1 (pituitary) |
C00001497
|
9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00001497
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001497
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001497
|
155 | ADRB3, BETA3AR | adrenoceptor beta 3 |
C00001497
|
250 | ALPP, ALP, PALP, PLAP, PLAP-1 | alkaline phosphatase, placental (EC:3.1.3.1) |
C00001497
|
551 | AVP, ADH, ARVP, AVP-NPII, AVRP, VP | arginine vasopressin |
C00001497
|
554 | AVPR2, ADHR, DI1, DIR, DIR3, NDI, V2R | arginine vasopressin receptor 2 |
C00001497
|
796 | CALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC | calcitonin-related polypeptide alpha |
C00001497
|
10498 | CARM1, PRMT4 | coactivator-associated arginine methyltransferase 1 (EC:2.1.1.125) |
C00001497
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00001497
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001497
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00001497
|
1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00001497
|
1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00001497
|
1269 | CNR2, CB-2, CB2, CX5 | cannabinoid receptor 2 (macrophage) |
C00001497
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00001497
|
1392 | CRH, CRF | corticotropin releasing hormone |
C00001497
|
1394 | CRHR1, CRF-R, CRF-R-1, CRF-R1, CRF1, CRFR-1, CRFR1, CRH-R-1, CRH-R1, CRH-R1h, CRHR, CRHR1L, CRHR1f | corticotropin releasing hormone receptor 1 |
C00001497
|
1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00001497
|
1584 | CYP11B1, CPN1, CYP11B, FHI, P450C11 | cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4) |
C00001497
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00001497
|
27185 | DISC1, C1orf136, SCZD9 | disrupted in schizophrenia 1 |
C00001497
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001497
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001497
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001497
|
2150 | F2RL1, GPR11, PAR2 | coagulation factor II (thrombin) receptor-like 1 |
C00001497
|
2488 | FSHB | follicle stimulating hormone, beta polypeptide |
C00001497
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001497
|
2778 | GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, NESP, PHP1A, PHP1B, PHP1C, POH | GNAS complex locus |
C00001497
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00001497
|
8843 | HCAR3, GPR109B, HCA3, HM74, PUMAG, Puma-g | hydroxycarboxylic acid receptor 3 |
C00001497
|
3269 | HRH1, H1-R, hisH1 | histamine receptor H1 |
C00001497
|
3274 | HRH2, H2R | histamine receptor H2 |
C00001497
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00001497
|
3350 | HTR1A, 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21, PFMCD | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
C00001497
|
3351 | HTR1B, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB, S12 | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
C00001497
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001497
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00001497
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001497
|
10681 | GNB5, GB5 | guanine nucleotide binding protein (G protein), beta 5 |
C00000094
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000094
|
3624 | INHBA, EDF, FRP | inhibin, beta A |
C00001497
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00001497
|
3972 | LHB, CGB4, LSH-B, hLHB | luteinizing hormone beta polypeptide |
C00001497
|
3973 | LHCGR, HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR, LHRHR, LSH-R, ULG5 | luteinizing hormone/choriogonadotropin receptor |
C00001497
|
3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00001497
|
4158 | MC2R, ACTHR | melanocortin 2 receptor (adrenocorticotropic hormone) |
C00001497
|
54539 | NDUFB11, CI-ESSS, ESSS, NP17.3, Np15, P17.3 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa |
C00001497
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00001497
|
10846 | PDE10A, HSPDE10A | phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17) |
C00001497
|
50940 | PDE11A, PPNAD2 | phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17) |
C00001497
|
5150 | PDE7A, HCP1, PDE7 | phosphodiesterase 7A (EC:3.1.4.17) |
C00001497
|
27115 | PDE7B, bA472E5.1 | phosphodiesterase 7B (EC:3.1.4.17) |
C00001497
|
5151 | PDE8A, HsT19550 | phosphodiesterase 8A (EC:3.1.4.17) |
C00001497
|
8622 | PDE8B, ADSD, PPNAD3 | phosphodiesterase 8B (EC:3.1.4.17) |
C00001497
|
5152 | PDE9A, HSPDE9A2 | phosphodiesterase 9A (EC:3.1.4.35) |
C00001497
|
5617 | PRL | prolactin |
C00001497
|
84432 | PROK1, EGVEGF, PK1, PRK1 | prokineticin 1 |
C00001497
|
5739 | PTGIR, IP, PRIPR | prostaglandin I2 (prostacyclin) receptor (IP) |
C00001497
|
5744 | PTHLH, BDE2, HHM, PLP, PTHR, PTHRP | parathyroid hormone-like hormone |
C00001497
|
5908 | RAP1B, K-REV, RAL1B | RAP1B, member of RAS oncogene family |
C00001497
|
9376 | SLC22A8, OAT3 | solute carrier family 22 (organic anion transporter), member 8 |
C00001497
|
6518 | SLC2A5, GLUT-5, GLUT5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
C00001497
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001497
|
7252 | TSHB, TSH-B, TSH-BETA | thyroid stimulating hormone, beta |
C00001497
|
7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor |
C00001497
|
7432 | VIP, PHM27 | vasoactive intestinal peptide |
C00001497
|
7434 | VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R | vasoactive intestinal peptide receptor 2 |
C00001497
|
7474 | WNT5A, hWNT5A | wingless-type MMTV integration site family, member 5A |
C00001497
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00000919
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00000919
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000919
|
8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) |
C00000919
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000919
|
288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) |
C00000919
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00000919
|
51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00000919
|
140462 | ASB9 | ankyrin repeat and SOCS box containing 9 |
C00000919
|
9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 |
C00000919
|
9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 |
C00000919
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00000919
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000919
|
53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) |
C00000919
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000919
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00000919
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00000919
|
9071 | CLDN10, CPETRL3, OSP-L | claudin 10 |
C00000919
|
51208 | CLDN18, SFTA5, SFTPJ | claudin 18 |
C00000919
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000919
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00000919
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00000919
|
8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain |
C00000919
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00000919
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00000919
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00000919
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00000919
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000919
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00000919
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000919
|
64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) |
C00000919
|
1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 |
C00000919
|
1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 |
C00000919
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00000919
|
23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 |
C00000919
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000919
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00000919
|
2627 | GATA6 | GATA binding protein 6 |
C00000919
|
2633 | GBP1 | guanylate binding protein 1, interferon-inducible |
C00000919
|
81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa |
C00000919
|
373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00000919
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00000919
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00000919
|
2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) |
C00000919
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00000919
|
3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 |
C00000919
|
3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 |
C00000919
|
3226 | HOXC10, HOX3I | homeobox C10 |
C00000919
|
3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 |
C00000919
|
3449 | IFNA16, IFN-alphaO | interferon, alpha 16 |
C00000919
|
3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 |
C00000919
|
3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 |
C00000919
|
3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 |
C00000919
|
50805 | IRX4, IRXA3 | iroquois homeobox 4 |
C00000919
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000919
|
3691 | ITGB4, CD104 | integrin, beta 4 |
C00000919
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00000919
|
3880 | KRT19, CK19, K19, K1CS | keratin 19 |
C00000919
|
3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 |
C00000919
|
7127 | TNFAIP2, B94, EXOC3L3 | tumor necrosis factor, alpha-induced protein 2 |
C00000094
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00000919
|
8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 |
C00000919
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000919
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00000919
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00000919
|
4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 |
C00000919
|
4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 |
C00000919
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00000919
|
3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00000919
|
4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 |
C00000919
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00000919
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000919
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00000919
|
5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 |
C00000919
|
5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 |
C00000919
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00000919
|
57088 | PLSCR4, TRA1 | phospholipid scramblase 4 |
C00000919
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00000919
|
5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D |
C00000919
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00000919
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000919
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00000919
|
5950 | RBP4, RDCCAS | retinol binding protein 4, plasma |
C00000919
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00000919
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000919
|
4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 |
C00000919
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000919
|
9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) |
C00000919
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000919
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000919
|
7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) |
C00000919
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00000919
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000919
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00000919
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00000919
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#117800 | Apocrine gland secretion, variation in |
Q96J66
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#210900 | Bloom syndrome; blm |
P54132
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P28907
(marker)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00000911
C00000919 |
D009369 | Neoplasms |
C00000911
C00000919 |
D013375 | Substance Withdrawal Syndrome |
C00001497
|
D007248 | Infertility, Male |
C00000911
|
D007249 | Inflammation |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D006943 | Hyperglycemia |
C00000911
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D011471 | Prostatic Neoplasms |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D013733 | Testicular Diseases |
C00000911
|
D014178 | Translocation, Genetic |
C00000911
|
D015431 | Weight Loss |
C00000911
|
D001249 | Asthma |
C00001497
|
D004409 | Dyskinesia, Drug-Induced |
C00001497
|
D006930 | Hyperalgesia |
C00001497
|
D006973 | Hypertension |
C00001497
|
D020326 | Migraine without Aura |
C00001497
|
D006965 | Hyperplasia |
C00000911
|
D014202 | Tremor |
C00001497
|
D000435 | Alcoholic Intoxication |
C00000919
|
D001145 | Arrhythmias, Cardiac |
C00000919
|
D053627 | Asthenozoospermia |
C00000919
|
D002545 | Brain Ischemia |
C00000919
|
D006528 | Carcinoma, Hepatocellular |
C00000919
|
D002318 | Cardiovascular Diseases |
C00000919
|
D003930 | Diabetic Retinopathy |
C00000919
|
D006526 | Hepatitis C |
C00000919
|
D015658 | HIV Infections |
C00000919
|
D006986 | Hypervitaminosis A |
C00000919
|
D008107 | Liver Diseases |
C00000919
|
D008113 | Liver Neoplasms |
C00000919
|
D008114 | Liver Neoplasms, Experimental |
C00000919
|
D008175 | Lung Neoplasms |
C00000919
|
D009845 | Oligospermia |
C00000919
|
D013272 | Stomach Diseases |
C00000919
|
D013276 | Stomach Ulcer |
C00000919
|